4//SEC Filing
Winters Chad 4
Accession 0001127602-25-006118
CIK 0000105770other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:09 PM ET
Size
13.1 KB
Accession
0001127602-25-006118
Insider Transaction Report
Form 4
Winters Chad
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+82.054$17,313→ 1,390.752 total - Tax Payment
Common Stock
2025-02-18$211.00/sh−27.727$5,850→ 1,363.025 total - Award
Stock Option (Right to Buy)
2025-02-18+822→ 822 totalExercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (822 underlying) - Award
Rst. Stock Unit
2025-02-18+356→ 356 totalExercise: $0.00→ Common Stock (356 underlying)
Footnotes (1)
- [F1]This award vests in four equal installments beginning on February 18, 2026.
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001811424
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:09 PM ET
- Size
- 13.1 KB